Immunovant finalizes CEO Eric Venker's employment agreement with $672K salary, equity awards

Immunovant, Inc.

Annual base salary $672,000; target annual bonus 72.25% of base salary.
Option Awards: 1,300,000 stock options and options valued at $2,250,000 (189,900 shares), four-year vest.
CVAR Award: 1,475,000 capped appreciation rights with performance and $16.76 stock price hurdle.
Two-year holding period on vested shares from Unit Option Award and 87.25% of CVAR-settled shares.
Severance: 12 months salary + target bonus + COBRA if terminated without cause or for good reason.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.